Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Vitamin A liposome artificial lacrimal eye drops

A technology of artificial tears and vitamins, applied in liposome delivery, active ingredients of hydroxyl compounds, organic active ingredients, etc., can solve problems affecting vision and eye movement, tear reduction, foreign body sensation in patients, etc.

Active Publication Date: 2006-10-25
CHINA RESOURCES SAIKE PHARMA
View PDF0 Cites 16 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] 5. Due to other reasons such as contact lenses, allergic conjunctivitis, air pollution, ultraviolet rays, etc., the tears are reduced and the quality is reduced
[0025] The administration of eye drops, due to the action of eyeball movement and the nasolacrimal system, causes a large amount of drug loss, which requires multiple administrations every day, the dosage is inaccurate, and the concentration of the drug in the eye fluctuates greatly; the administration of suspension or ointment also affects vision and eye movements
In order to overcome the above shortcomings, add hydrophilic gel carbomer (carbomer) to increase the viscosity, delay the residence time of the drug, and increase the absorption; but it is easy to blur the vision and affect the eyelid movement; or implant a long-acting controlled release drug delivery system , but the patient has a foreign body sensation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0082] Prescription: 1000ml fat-soluble vitamin A liposome

[0083] Vitamin A palmitate or vitamin A acetate (calculated as vitamin A) 0.25g

[0084] Soy Lecithin 8.90g

[0085] Cholesterol 1.10g

[0086] Vitamin E 0.05g

[0087] 1000ml

[0088] Preparation of hydration solution: 1000ml

[0089] Sodium bicarbonate 0.20g

[0090] Sodium chloride 9.00g

[0091] Glucose 1.00g

[0092] Potassium chloride 0.14g

[0093] Calcium chloride 0.42g

[0094] 1000ml

[0095] pH value: 5.0~7.0

[0096] The preparation method is as follows:

[0097] 1. Weigh the prescribed amount of vitamin A palmitate or vitamin A acetate, soybean lecithin, cholesterol, vitamin E, and dissolve it with chloroform or absolute ethanol or ether or petroleum ether.

[0098] 2. Put the lipid solution on a thin film evaporator, and remove the organic solvent under reduced pressure to obtain a lipid film.

[0099] 3. Prepare the hydration solution acc...

Embodiment 2

[0103] Prescription: 1000ml fat-soluble vitamin A liposome

[0104] Vitamin A palmitate or vitamin A acetate (calculated as vitamin A) 0.5g

[0105] Soy Lecithin 8.25g

[0106] Cholesterol 1.75g

[0107] Vitamin E 0.05g

[0108] 1000ml

[0109] Preparation of hydration solution: 1000ml

[0110] Sodium bicarbonate 0.20g

[0111] Sodium chloride 9.00g

[0112] Glucose 1.00g

[0113] Potassium chloride 0.14g

[0114] Calcium chloride 0.42g

[0115] Menthol 10mg

[0116] PVP 20mg

[0117] 1000ml

[0118] pH value: 5.0~7.0

[0119] The preparation method is the same as in Example 1.

Embodiment 3

[0121] Prescription: 1000ml fat-soluble vitamin A liposome

[0122] Vitamin A palmitate or vitamin A acetate (calculated as vitamin A) 1.0g

[0123] Soy Lecithin 7.52g

[0124] Cholesterol 2.48g

[0125] Vitamin E 0.05g

[0126] 1000ml

[0127] Preparation of hydration solution: 1000ml

[0128] Sodium bicarbonate 0.20g

[0129] Sodium chloride 9.00g

[0130] Glucose 1.00g

[0131] Potassium chloride 0.14g

[0132] Calcium chloride 0.42g

[0133] HPMC 250mg

[0134] 1000ml

[0135] pH value: 5.0~7.0

[0136] The preparation method is the same as in Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a vitamin A liposome artificial tears eye drops for preventing and curing xerophthalmia and ophthalmokopia. Its composition includes fat-soluble vitamin A, liposome encapsulating material, vitamin E and artificial tears hydrated liquor, in which the fat-soluble vitamin A is vitamin A palmitate or vitamin A acetate, the liposome encapsulating material is soya bean lecithin and cholesterol, and the composition of artificial tears hydrated liquor includes sodium hydrogen carbonate, sodium chloride, glucose, potassium chloride, calcium chloride and water. Besides, according to requirements one or several kinds of auxiliary components of menthanol, PVP and HPMC, etc. also can be added.

Description

Technical field: [0001] The invention relates to an eye drop, in particular to a liposome artificial tear eye drop containing vitamin A. For the prevention and treatment of dry eye disease and eye fatigue. Background technique: [0002] The causes of dry eye or dry conjunctiva and dry eye mainly include the following aspects: [0003] 1. Due to physiological reasons such as advanced age, lack of sleep, and mental stress, the quality of tears is reduced. [0004] 2. The effect of taking some antihypertensive drugs and some neuroleptics on tear production. At present, some contraceptives can reduce tear production. [0005] 4. Engaged in computer operation, car driving, reading and other fine work for a long time. [0006] 5. Due to other reasons such as contact lenses, allergic conjunctivitis, air pollution, ultraviolet rays, etc., the tears are reduced and the quality is reduced. [0007] 6. Patients with dry eye syndrome are sensitive to airflow, and the cornea is parti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/127A61K31/07A61K31/355A61P27/02
Inventor 孙猛孙仁俊
Owner CHINA RESOURCES SAIKE PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products